Repositori DSpace/Manakin

Genetic evidence of heterogeneity in intrahepatic cholestasis of pregnancy

Mostra el registre parcial de l'element

dc.creator Savander, M.
dc.creator Ropponen, A.
dc.creator Avela, K.
dc.creator Weerasekera, N.
dc.creator Cormand Rifà, Bru
dc.creator Hirvioja, M. L.
dc.creator Riikonen, S.
dc.creator Ylikorkala, O.
dc.creator Lehesjoki, A. E.
dc.creator Williamson, C.
dc.creator Aittomäki, Kristiina
dc.date 2011-07-07T11:32:51Z
dc.date 2011-07-07T11:32:51Z
dc.date 2003
dc.date.accessioned 2024-12-16T10:27:13Z
dc.date.available 2024-12-16T10:27:13Z
dc.identifier 0017-5749
dc.identifier http://hdl.handle.net/2445/18627
dc.identifier 504108
dc.identifier 12801961
dc.identifier.uri http://fima-docencia.ub.edu:8080/xmlui/handle/123456789/22083
dc.description Background and aims: The aim of this study was to investigate the genetic aetiology of intrahepatic cholestasis of pregnancy (ICP) and the impact of known cholestasis genes (BSEP, FIC1, and MDR3) on the development of this disease. Patients and methods: Sixty nine Finnish ICP patients were prospectively interviewed for a family history of ICP, and clinical features were compared in patients with familial ICP (patients with a positive family history, n=11) and sporadic patients (patients with no known family history of ICP, n=58). For molecular genetic analysis, 16 individuals from two independently ascertained Finnish ICP families were genotyped for the flanking markers for BSEP, FIC1, and MDR3. Results: The pedigree structures in 16% (11/69) of patients suggested dominant inheritance. Patients with familial ICP had higher serum aminotransferase levels and a higher recurrence risk (92% v 40%). Both segregation of haplotypes and multipoint linkage analysis excluded BSEP, FIC1, and MDR3 genes in the studied pedigrees. Additionally, the MDR3 gene, previously shown to harbour mutations in ICP patients, was negative for mutations when sequenced in four affected individuals from the two families. Conclusions: These results support the hypothesis that the aetiology of ICP is heterogeneous and that ICP is due to a genetic predisposition in a proportion of patients. The results of molecular genetic analysis further suggest that the previously identified three cholestasis genes are not likely to be implicated in these Finnish ICP families with dominant inheritance.
dc.format 6 p.
dc.format application/pdf
dc.language eng
dc.publisher BMJ Group
dc.relation Reproducció digital del document publicat a: http://dx.doi.org/10.1136/gut.52.7.1025
dc.relation Gut, 2003, vol. 52, núm. 7, p. 1025-1029
dc.relation http://dx.doi.org/10.1136/gut.52.7.1025
dc.rights (c) BMJ Publishing Group Ltd and British Society of Gastroenterology, 2003
dc.rights info:eu-repo/semantics/openAccess
dc.source Articles publicats en revistes (Genètica, Microbiologia i Estadística)
dc.subject Genètica mèdica
dc.subject Embaràs
dc.subject Colèdoc
dc.subject Inflamació
dc.subject Malalties del fetge
dc.subject Medical genetics
dc.subject Pregnancy
dc.subject Choledochus
dc.subject Inflammation
dc.subject Liver diseases
dc.title Genetic evidence of heterogeneity in intrahepatic cholestasis of pregnancy
dc.type info:eu-repo/semantics/article
dc.type info:eu-repo/semantics/publishedVersion


Fitxers en aquest element

Fitxers Grandària Format Visualització

No hi ha fitxers associats a aquest element.

Aquest element apareix en la col·lecció o col·leccions següent(s)

Mostra el registre parcial de l'element

Cerca a DSpace


Cerca avançada

Visualitza

El meu compte